Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomised, Double-blind, Placebo-controlled, Parallel-group, Dose-range Trial to Investigate the Efficacy and Safety of FE 999302 as add-on Treatment to Follitropin Delta (REKOVELLE) in Women Undergoing Controlled Ovarian Stimulation in a Long GnRH Agonist Protocol
Brief Summary: The purpose of this phase 2 dose-ranging trial is to investigate the effects of FE 999302 on parameters influencing pregnancy rates in women undergoing Controlled Ovarian Stimulation (COS) with follitropin delta in a long gonadotropin releasing hormone (GnRH) agonist protocol.

Furthermore, the study intends:

* To investigate the safety of FE 999302 in women undergoing COS with follitropin delta in a long GnRH agonist protocol.
* To investigate the potential immunogenicity of FE 999302 in subjects undergoing COS with follitropin delta in a long GnRH agonist protocol.
* To estimate the impact of body weight on FE 999302 exposure in subjects undergoing COS with follitropin delta in a long GnRH agonist protocol.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Patients receiving short protocol IVF/ICSI-treatment. | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Long protocol | Intervention Type: DRUG; Name: Patients receiving short protocol IVF/ICSI-treatment.; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Long protocol; Assigned to Arm(s): 2
B: Arm Label: FE 999302 (1 μg) and follitropin delta; Type: EXPERIMENTAL; Interventions: Drug: FE 999302 (1 μg) and follitropin delta | Arm Label: FE 999302 (2 μg) and follitropin delta; Type: EXPERIMENTAL; Interventions: Drug: FE 999302 (2 μg) and follitropin delta | Arm Label: FE 999302 (4 μg) and follitropin delta; Type: EXPERIMENTAL; Interventions: Drug: FE 999302 (4 μg) and follitropin delta | Arm Label: FE 999302 (8 μg) and follitropin delta; Type: EXPERIMENTAL; Interventions: Drug: FE 999302 (8 μg) and follitropin delta | Arm Label: FE 999302 (12 μg) and follitropin delta; Type: EXPERIMENTAL; Interventions: Drug: FE 999302 (12 μg) and follitropin delta | Arm Label: Placebo and follitropin delta; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo and follitropin delta | Intervention Type: DRUG; Name: FE 999302 (1 μg) and follitropin delta; Assigned to Arm(s): FE 999302 (1 μg) and follitropin delta | Intervention Type: DRUG; Name: FE 999302 (2 μg) and follitropin delta; Assigned to Arm(s): FE 999302 (2 μg) and follitropin delta | Intervention Type: DRUG; Name: FE 999302 (4 μg) and follitropin delta; Assigned to Arm(s): FE 999302 (4 μg) and follitropin delta | Intervention Type: DRUG; Name: FE 999302 (8 μg) and follitropin delta; Assigned to Arm(s): FE 999302 (8 μg) and follitropin delta | Intervention Type: DRUG; Name: FE 999302 (12 μg) and follitropin delta; Assigned to Arm(s): FE 999302 (12 μg) and follitropin delta | Intervention Type: OTHER; Name: Placebo and follitropin delta; Assigned to Arm(s): Placebo and follitropin delta
C: Arm Label: Highly Purified Menotrophin; Type: EXPERIMENTAL; Interventions: Drug: Highly purified menotrophin | Arm Label: Recombinant FSH; Type: ACTIVE_COMPARATOR; Interventions: Drug: Recombinant FSH | Intervention Type: DRUG; Name: Highly purified menotrophin; Assigned to Arm(s): Highly Purified Menotrophin | Intervention Type: DRUG; Name: Recombinant FSH; Assigned to Arm(s): Recombinant FSH
D: Arm Label: CONSORT Dosing; Type: EXPERIMENTAL; Interventions: Drug: GONAL f® prefilled pen | Arm Label: Standard Dosing; Type: ACTIVE_COMPARATOR; Interventions: Drug: GONAL f® prefilled pen | Intervention Type: DRUG; Name: GONAL f® prefilled pen; Assigned to Arm(s): CONSORT Dosing | Intervention Type: DRUG; Name: GONAL f® prefilled pen; Assigned to Arm(s): Standard Dosing

Answer: B